Related Experiment Video
Updated: Aug 4, 2026

Colon Ascendens Stent Peritonitis (CASP) - a Standardized Model for Polymicrobial Abdominal Sepsis
Published on: December 18, 2010
Piperacillin in paediatric surgery
Insights
Piperacillin, a broad-spectrum penicillin antibiotic, demonstrated effectiveness and safety in treating various infections in 23 infants and children. Clinical responses were positive with minimal adverse reactions observed during the study.
Area of Science:
- Pediatric Infectious Diseases
- Pharmacology
- Antimicrobial Agents
Background:
- Piperacillin is a novel semi-synthetic penicillin.
- It exhibits broad-spectrum antimicrobial activity.
- Its use in pediatric populations requires evaluation.
Purpose of the Study:
- To assess the efficacy and safety of piperacillin in pediatric patients.
- To evaluate piperacillin's effectiveness across diverse infection types.
- To document adverse reactions associated with piperacillin treatment in children.
Main Methods:
- A cohort of 23 infants and children (aged 1 month to 15 years) received piperacillin.
- Indications included perforated appendicitis, urinary tract infections, miscellaneous infections, and prophylactic treatment.
- Clinical outcomes and adverse events were monitored.
Main Results:
- Good clinical responses were observed in the treated patients.
- Piperacillin was effective in managing perforated appendicitis with peritonitis or abscess.
- Few adverse reactions were reported, indicating a favorable safety profile.
Conclusions:
- Piperacillin appears to be an effective and safe treatment option for various infections in pediatric patients.
- The antibiotic demonstrated a good clinical response with a low incidence of adverse effects.
- Further investigation into piperacillin's role in pediatric infectious disease management is warranted.
Abstract:
23 infants and children, aged 1 month - 15 years, were treated with piperacillin, a new semi-synthetic penicillin with a broad spectrum of activity. The indications were perforated appendicitis with peritonitis or abscess formation (12 patients), urinary tract infection due to congenital anomalies (3 patients), miscellaneous infections (3 patients) and peroperative prophylactic treatment (5 patients). The clinical response was good. Few adverse reactions were noted. The drug seems to be effective and safe.
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Acute Pyelonephritis II: Diagnostic Studies and Management

